(Q74272965)
Statements
An Open Label, Randomized, Three-treatment, Three-sequence, Three-period, Cross-over, Pharmacokinetic and Adhesion Performance Study of Lidocaine Patch 36 mg/Patch (1.8%) in Fasting, Healthy, Adult, Human Subjects, With Physical Exercise, Heat and Normal Conditions. (English)
0 references
8 January 2016
0 references
25 January 2016
0 references
12
0 references
18 year
0 references